81 related articles for article (PubMed ID: 1334882)
1. [The role of the sympathetic cholinergic pathway in the neurogenic control of the release of tissue-type plasminogen activator into the blood].
Bashkov GB; Sergeev IIu; Medvedeva NA; Makarov VA
Fiziol Zh SSSR Im I M Sechenova; 1992 May; 78(5):60-7. PubMed ID: 1334882
[TBL] [Abstract][Full Text] [Related]
2. Role of sympathetic cholinergic pathway in the neurogenous control of tissue-type plasminogen activator release into the blood.
Bashkov GV; Sergeev IYu ; Medvedeva NA
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):993-8. PubMed ID: 7908542
[TBL] [Abstract][Full Text] [Related]
3. [The stimulation of fibrinolysis during cholinergic vasodilating reactions].
Bashkov GV; Sergeev IIu; Medvedeva NA; Makarov VA
Fiziol Zh (1978); 1990; 36(4):3-8. PubMed ID: 2146171
[TBL] [Abstract][Full Text] [Related]
4. Cardiac sympathetic nerve stimulation triggers coronary t-PA release.
Björkman JA; Jern S; Jern C
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1091-7. PubMed ID: 12714432
[TBL] [Abstract][Full Text] [Related]
5. Release of tissue-type plasminogen activator (t-PA) in the splanchnic circulation of the anaesthetised pig during high sympathetic tone.
Björkman JA; Ilebekk A; Jern C
Thromb Res; 2010 Mar; 125(3):e106-9. PubMed ID: 19931890
[TBL] [Abstract][Full Text] [Related]
6. Enhanced vascular plasminogen activator (t-PA) release by epinephrine in aged rats.
Iacoviello L; D'Adamo MC; De Curtis A; Buczko W; Donati MB
Thromb Haemost; 1995 May; 73(5):841-4. PubMed ID: 7482413
[TBL] [Abstract][Full Text] [Related]
7. Stimulated release of tissue plasminogen activator from artery wall sympathetic nerves: implications for stress-associated wall damage.
Hao Z; Jiang X; Sharafeih R; Shen S; Hand AR; Cone RE; O'Rourke J
Stress; 2005 Jun; 8(2):141-9. PubMed ID: 16019605
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic inhibition of sympathetic vasoconstrictor tone in the cerebrovascular bed mediated by nicotinic-type receptors.
Owman C; Aubineau P; Edvinsson L; Sercombe R
Acta Physiol Scand Suppl; 1980; 479():39-42. PubMed ID: 6932804
[TBL] [Abstract][Full Text] [Related]
9. Evidence of a net release of tissue-type plasminogen activator across the human cerebral vasculature.
Jern C; Blomstrand C; Westerlind A
Thromb Haemost; 2004 May; 91(5):1019-25. PubMed ID: 15116264
[TBL] [Abstract][Full Text] [Related]
10. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R
J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057
[TBL] [Abstract][Full Text] [Related]
11. Additional evidence that the sympathetic nervous system regulates the vessel wall release of tissue plasminogen activator.
Wang Y; Jiang X; Hand AR; Gilles C; Kirk J; Cone RE; O'Rourke J
Blood Coagul Fibrinolysis; 2002 Sep; 13(6):471-81. PubMed ID: 12192298
[TBL] [Abstract][Full Text] [Related]
12. Sympathoadrenal activation and muscarinic receptor stimulation induce acute release of tissue-type plasminogen activator but not von Willebrand factor across the human forearm.
Jern C; Selin L; Tengborn L; Jern S
Thromb Haemost; 1997 Aug; 78(2):887-91. PubMed ID: 9268190
[TBL] [Abstract][Full Text] [Related]
13. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
Modin A
Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nitric oxide synthesis augments centrally induced sympathetic coronary vasoconstriction in cats.
Goodson AR; Leibold JM; Gutterman DD
Am J Physiol; 1994 Oct; 267(4 Pt 2):H1272-8. PubMed ID: 7943371
[TBL] [Abstract][Full Text] [Related]
15. Prostacyclin is required for t-PA release after venous occlusion.
Iacoviello L; De Curtis A; D'Adamo MC; Amore C; Buczko W; De Gaetano G; Donati MB
Am J Physiol; 1994 Feb; 266(2 Pt 2):H429-34. PubMed ID: 7511345
[TBL] [Abstract][Full Text] [Related]
16. [The role of cholinergic receptors in the reactions of the hemostasis system to vasopressin].
Kalishevskaia TM; Golubeva MG; Solo'veva ME
Fiziol Zh (1978); 1989; 35(5):9-14. PubMed ID: 2591588
[TBL] [Abstract][Full Text] [Related]
17. Different cardiac tissue plasminogen activator release patterns by local stimulation of the endothelium and sympathetic nerves in pigs.
Aspelin T; Eriksen M; Ilebekk A; Björkman JA; Lyberg T
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):714-22. PubMed ID: 22964765
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
19. Possibilities for a cholinergic action on smooth musculature and on sympathetic axons in brain vessels mediated by muscarinic and nicotinic receptors.
Edvinsson L; Falck B; Owman C
J Pharmacol Exp Ther; 1977 Jan; 200(1):117-26. PubMed ID: 833753
[TBL] [Abstract][Full Text] [Related]
20. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
